Stock Chart

AMLX

$32.41 -4.51%
Score: 57.0 HOLD
LEAPs: SELL $22
i
LEAPs Option Signal

Type: SELL wallstreet
Strike: $22
Premium: $6.33
Expiry: Jan 15, 2027
Target: $22
Score: -95

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 0.89x (vs SPY: 0.5x | vs QQQ: 0.6x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Sep 18, 2026
Bear Pennant Bearish scenario quality 74/100
Setup invalidates on a close above $34.33 · pole −24% — no price target (measured-move targets failed our backtest for flags/pennants)
Historically breaks down 70% of the time (n=1,730). Measured-move targets failed our backtest — none shown.
Pattern detection is automated and probabilistic — a scenario map for levels, not a buy/sell signal. Rails, projected path and invalidation level are drawn on the chart below.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About AMLX - Amylyx Pharmaceuticals, Inc. Common Stock

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

Key Statistics

Market Cap $4B

This AMLX stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track AMLX's price movements with trendlines, gamma walls, and key support/resistance levels.